Related Experiment Video
Updated: May 27, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Splicing programs and cancer
Sophie Germann1, Lise Gratadou, Martin Dutertre
1Université de Lyon, 28 rue Laënnec, 69008 Lyon, France.
Abstract:
Numerous studies report splicing alterations in a multitude of cancers by using gene-by-gene analysis. However, understanding of the role of alternative splicing in cancer is now reaching a new level, thanks to the use of novel technologies allowing the analysis of splicing at a large-scale level. Genome-wide analyses of alternative splicing indicate that splicing alterations can affect the products of gene networks involved in key cellular programs. In addition, many splicing variants identified as being misregulated in cancer are expressed in normal tissues. These observations suggest that splicing programs contribute to specific cellular programs that are altered during cancer initiation and progression. Supporting this model, recent studies have identified splicing factors controlling cancer-associated splicing programs. The characterization of splicing programs and their regulation by splicing factors will allow a better understanding of the genetic mechanisms involved in cancer initiation and progression and the development of new therapeutic targets.
Insights
Alternative splicing alterations are increasingly recognized in cancer. Large-scale analyses reveal these changes impact key cellular networks, offering new therapeutic targets for cancer initiation and progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gene-by-gene analysis has identified splicing alterations in various cancers.
- Novel technologies enable large-scale analysis of alternative splicing in cancer.
Purpose of the Study:
- To explore the role of alternative splicing in cancer at a large scale.
- To understand how splicing alterations contribute to cancer initiation and progression.
- To identify splicing factors regulating cancer-associated splicing programs.
Main Methods:
- Genome-wide analyses of alternative splicing.
- Identification of misregulated splicing variants in cancer.
- Studies on splicing factors controlling cancer-associated splicing programs.
Main Results:
- Alternative splicing alterations affect gene networks crucial for cellular programs.
- Many cancer-associated splicing variants are also present in normal tissues.
- Splicing factors have been identified that control cancer-associated splicing programs.
Conclusions:
- Splicing programs are altered during cancer initiation and progression.
- Characterizing splicing programs and their regulation is key to understanding cancer genetics.
- Splicing factors and programs represent potential therapeutic targets for cancer treatment.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pre-mRNA Processing: RNA Splicing
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
